HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Stéphane Leprêtre Selected Research
Stéphane Leprêtre Research Topics
Disease
14
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
06/2022 - 06/2011
4
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2022 - 01/2018
4
Infections
07/2022 - 10/2009
4
Neoplasms (Cancer)
06/2022 - 05/2015
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 09/2015
3
Leukemia
01/2021 - 11/2018
2
Philadelphia Chromosome
01/2020 - 09/2015
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2019 - 08/2017
2
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2015 - 05/2013
2
Sarcopenia
07/2014 - 04/2014
1
Venous Thrombosis (Deep-Vein Thrombosis)
07/2022
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2022
1
Rheumatoid Arthritis
01/2022
1
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022
1
Waldenstrom Macroglobulinemia (Macroglobulinemia)
11/2021
1
Trisomy (Trisomies)
01/2020
1
Neutropenia
02/2018
1
B-Cell Lymphoma (Lymphoma, B Cell)
01/2018
1
Pancreatitis
09/2015
1
Hypersensitivity (Allergy)
09/2015
1
Febrile Neutropenia
05/2015
1
Cachexia
07/2014
1
Peritonitis
06/2014
1
Sepsis (Septicemia)
06/2014
1
Limbic Encephalitis (Paraneoplastic Limbic Encephalitis)
05/2013
1
Residual Neoplasm
03/2012
Drug/Important Bio-Agent (IBA)
13
Rituximab (Mabthera)
FDA Link
01/2022 - 03/2012
4
fludarabine
IBA
01/2020 - 02/2016
4
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2020 - 02/2016
3
Biological Products
IBA
01/2021 - 01/2019
2
Monoclonal Antibodies
IBA
01/2022 - 01/2017
2
Asparaginase (Elspar)
FDA Link
01/2019 - 09/2015
2
Alemtuzumab (Campath)
FDA Link
01/2018 - 03/2012
1
Antigens
IBA
01/2022
1
idelalisib
IBA
11/2021
1
obinutuzumab
IBA
11/2021
1
Thymidine Kinase
IBA
01/2020
1
ponatinib
IBA
01/2020
1
Aspartate-Ammonia Ligase (Asparagine Synthetase)
IBA
01/2019
1
DNA (Deoxyribonucleic Acid)
IBA
01/2019
1
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
11/2018
1
Cell-Free Nucleic Acids
IBA
01/2018
1
Cytokine Receptors (Cytokine Receptor)
IBA
08/2017
1
Histones (Histone)
IBA
08/2017
1
RNA (Ribonucleic Acid)
IBA
01/2017
1
Biomarkers (Surrogate Marker)
IBA
01/2017
1
CD20 Antigens
IBA
01/2017
1
Lipase (Acid Lipase)
FDA Link
09/2015
1
Platinum
IBA
08/2015
1
Cytarabine (Cytosar-U)
FDA Link
Generic
08/2015
1
Transcription Factors (Transcription Factor)
IBA
06/2015
1
Dasatinib (BMS 354825)
FDA Link
06/2015
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
06/2015
1
Core Binding Factors (Core-Binding Factor)
IBA
06/2015
1
Fluorine-18
IBA
05/2015
1
Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)
IBA
05/2013
1
Purine Nucleosides
IBA
03/2012
1
Pharmaceutical Preparations
IBA
10/2009
Therapy/Procedure
6
Therapeutics
06/2022 - 06/2015
4
Drug Therapy (Chemotherapy)
05/2015 - 04/2014
1
Vascular Access Devices (Arterial Line)
07/2022
1
Catheters
07/2022
1
Central Venous Catheters
05/2015
1
Immunotherapy
03/2012
1
Stem Cell Transplantation
06/2011